The caller alleged discrepant low inratio inr results in comparison to the laboratory inr result.Results are as follows: date: (b)(6) 2015; inratio inr: 2.4 and 2.6; laboratory inr: 5.9.Therapeutic range: 2.5 - 3.0.The time between the first inratio inr and the laboratory inr was two (2) hours.After the laboratory inr, the customer retested two (2) hours later on the inratio.The customer reported having hematuria.It is unknown if the hematuria was related to a kidney stone the customer reported having, the elevated inr or a combination of both.Coumadin was held the evening of (b)(6) 2015.There was no other treatment administered.There was no additional information provided.
|
Investigation/conclusion: it is indicated that the product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.The retain strip testing results met both accuracy and strip repeatability criteria.The product performed as expected and no product deficiencies were observed.A review of the manufacturing records for the lot did not uncover any relevant non-conformances and the lot met release specification.The root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency and no corrective action is required at this time.
|